中国头颈部肿瘤放射治疗指南(2021年版)

摘要/Abstract

中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会. 中国头颈部肿瘤放射治疗指南(2021年版)[J]. 国际肿瘤学杂志, 2022, 49(2): 65-72.

图/表1

表1

不同原发部位的头颈部肿瘤淋巴结转移分布(%)"

发病部位	Ⅰ区	Ⅱ区	Ⅲ区	Ⅳ区	Ⅴ区
扁桃体	9	88	23	9	10
舌根	6	76	24	9	7
舌侧缘	5	38	19	19	5
舌腹	19	38	19	19	5
颊黏膜	62	31	8	0	0
上牙龈	14	57	14	14	0
下牙龈	46	38	15	0	0
磨牙后三角	19	71	5	5	0
口底	46	29	14	11	0
口咽	3	67	14	10	5
下咽	10	78	75	47	11
喉	8	68	70	35	5

表1

参考文献41

[1]	Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment[J]. Mayo Clin Proc, 2016, 91(3): 386-396. DOI: 10.1016/j.mayocp.2015.12.017. doi:10.1016/j.mayocp.2015.12.017
[2]	Amsbaugh MJ, Yusuf M, Cash E, et al. Distribution of cervical lymph node metastases from squamous cell carcinoma of the oropha-rynx in the era of risk stratification using human papillomavirus and smoking status[J]. Int J Radiat Oncol Biol Phys, 2016, 96(2): 349-353. DOI: 10.1016/j.ijrobp.2016.06.2450. doi:10.1016/j.ijrobp.2016.06.2450
[3]	Chung EJ, Lee SH, Baek SH, et al. Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma[J]. Laryngoscope, 2014, 124(4): 882-887. DOI: 10.1002/lary.24299. doi:10.1002/lary.24299
[4]	Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract[J]. Am J Surg, 1990, 160(4): 405-409. DOI: 10.1016/s0002-9610(05)80554-9. doi:10.1016/s0002-9610(05)80554-9pmid:2221244
[5]	Wacławek M, Miłoński J, Olszewski J. Comparative evaluation of the diagnostic value of biopsy and NBI endoscopy in patients with cancer of the hypopharynx and larynx[J]. Otolaryngol Pol, 2019, 73(5): 12-17. DOI: 10.5604/01.3001.0013.2309. doi:10.5604/01.3001.0013.2309
[6]	Tanaka S, Morita Y, Fujita T, et al. Clinicopathological characteristics of abnormal micro-lesions at the oro-hypopharynx detected by a magnifying narrow band imaging system[J]. Dig Endosc, 2012, 24(2): 100-109. DOI: 10.1111/j.1443-1661.2011.01177.x. doi:10.1111/j.1443-1661.2011.01177.x
[7]	Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas[J]. J Nucl Med, 1995, 36(10): 1747-1757. pmid:7562038
[8]	Yao M, Smith RB, Hoffman HT, et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer—a long-term outcome report[J]. Int J Radiat Oncol Biol Phys, 2009, 74(1): 9-14. DOI: 10.1016/j.ijrobp.2008.07.019. doi:10.1016/j.ijrobp.2008.07.019
[9]	Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer[J]. Head Neck, 2005, 27(3): 175-181. DOI: 10.1002/hed.20130. doi:10.1002/hed.20130
[10]	田家军, 徐伟, 吕正华, 等. 电子胃镜在下咽鳞状细胞癌术前检查中的应用[J]. 中华耳鼻咽喉头颈外科杂志, 2018, 53(4): 292-295. DOI: 10.3760/cma.j.issn.1673-0860.2018.04.010. doi:10.3760/cma.j.issn.1673-0860.2018.04.010
[11]	Huang YC, Lee YC, Tseng PH, et al. Regular screening of esophageal cancer for 248 newly diagnosed hypopharyngeal squamous cell carcinoma by unsedated transnasal esophagogastroduodenoscopy[J]. Oral Oncol, 2016, 55:55-60. DOI: 10.1016/j.oraloncology.2016.01.008. doi:10.1016/j.oraloncology.2016.01.008
[12]	Boute P, Page C, Biet A, et al. Epidemiology, prognosis and treatment of simultaneous squamous cell carcinomas of the oral cavity and hypopharynx[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2014, 131(5): 283-287. DOI: 10.1016/j.anorl.2013.10.003. doi:10.1016/j.anorl.2013.10.003pmid:25288121
[13]	Wycliffe ND, Grover RS, Kim PD, et al. Hypopharyngeal cancer[J]. Top Magn Reson Imaging, 2007, 18(4): 243-258. DOI: 10.1097/RMR.0b013e3181570c3f. doi:10.1097/RMR.0b013e3181570c3f
[14]	Tandon S, Shahab R, Benton JI, et al. Fine-needle aspiration cyto-logy in a regional head and neck cancer center: comparison with a systematic review and meta-analysis[J]. Head Neck, 2008, 30(9): 1246-1252. DOI: 10.1002/hed.20849. doi:10.1002/hed.20849
[15]	Adoga AA, Silas OA, Nimkur TL. Open cervical lymph node biopsy for head and neck cancers: any benefit?[J]. Head Neck Oncol, 2009, 1:9. DOI: 10.1186/1758-3284-1-9. doi:10.1186/1758-3284-1-9
[16]	Chow LQM. Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72. DOI: 10.1056/NEJMra1715715. doi:10.1056/NEJMra1715715
[17]	Braakhuis BJ, Brakenhoff RH, Leemans CR. Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors[J]. Ann Oncol, 2012, 23(Suppl 10): x173-x177. DOI: 10.1093/annonc/mds299. doi:10.1093/annonc/mds299
[18]	Eskander A, Irish J, Groome PA, et al. Volume-outcome relationships for head and neck cancer surgery in a universal health care system[J]. Laryngoscope, 2014, 124(9): 2081-2088. DOI: 10.1002/lary.24704. doi:10.1002/lary.24704
[19]	National Comprehensive Cancer Network. NCCN Guidelines Version 2.2021 Head and Neck Cancers[S]. Pennsylvania: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), 2021.
[20]	Howard J, Dwivedi RC, Masterson L, et al. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma[J]. Cochrane Database Syst Rev, 2018, 12(12): CD012939. DOI: 10.1002/14651858.CD012939.pub2. doi:10.1002/14651858.CD012939.pub2
[21]	Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetu-ximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial[J]. Lancet, 2019, 393(10166): 40-50. DOI: 10.1016/S0140-6736(18)32779-X. doi:S0140-6736(18)32779-Xpmid:30449625
[22]	Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis[J]. Lancet Oncol, 2014, 15(9): 1027-1038. DOI: 10.1016/S1470-2045(14)70268-2. doi:10.1016/S1470-2045(14)70268-2
[23]	Akbaba S, Ahmed D, Lang K, et al. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx[J]. Oral Oncol, 2019, 91:39-46. DOI: 10.1016/j.oraloncology.2019.02.019. doi:S1368-8375(19)30064-8pmid:30926061
[24]	Ikawa H, Koto M, Hayashi K, et al. Feasibility of carbon-ion radiotherapy for oral non-squamous cell carcinomas[J]. Head Neck, 2019, 41(6): 1795-1803. DOI: 10.1002/hed.25618. doi:10.1002/hed.25618
[25]	Blanchard P, Gunn GB, Lin A, et al. Proton therapy for head and neck cancers[J]. Semin Radiat Oncol, 2018, 28(1): 53-63. DOI: 10.1016/j.semradonc.2017.08.004. doi:S1053-4296(17)30085-1pmid:29173756
[26]	Lv X, Cao X, Xia WX, et al. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage Ⅲ-ⅣB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial[J]. Lancet Oncol, 2021, 22(5): 716-726. DOI: 10.1016/S1470-2045(21)00075-9. doi:10.1016/S1470-2045(21)00075-9
[27]	陈宇, 吴伟莉, 金风, 等. 时间调节诱导化疗序贯洛铂同期放化疗治疗局部晚期头颈部鳞癌临床分析[J]. 肿瘤防治研究, 2017, 44(10): 689-693. DOI: 10.3971/j.issn.1000-8578.2017.17.0031. doi:10.3971/j.issn.1000-8578.2017.17.0031
[28]	Zeng YC, Wu R, Xu ZG, et al. Safety and radiation-enhancing effect of sodium glycididazole in locoregionally advanced laryngeal cancers previously treated with platinum-containing chemotherapy regimens: a preliminary report[J]. Cancer Radiother, 2010, 14(1): 59-64. DOI: 10.1016/j.canrad.2009.06.022. doi:10.1016/j.canrad.2009.06.022pmid:19695922
[29]	Patil VM, Noronha V, Joshi A, et al. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer[J]. Cancer, 2019, 125(18): 3184-3197. DOI: 10.1002/cncr.32179. doi:10.1002/cncr.32179
[30]	王健仰, 黄晓东, 王凯, 等. 甘氨双唑钠降低头颈部鳞癌患者严重放射性黏膜炎的Ⅱ期随机临床研究[J]. 中华放射肿瘤学杂志, 2016, 25(7): 671-675. DOI: 10.3760/cma.j.issn.1004-4221.2016.07.002. doi:10.3760/cma.j.issn.1004-4221.2016.07.002
[31]	Wen Q, Ma QJ, Bai L, et al. Glycididazole sodium combined with radioiodine therapy for patients with differentiated thyroid carcinoma (DTC)[J]. Int J Clin Exp Med, 2015, 8(8): 14095-14099.
[32]	Lin HW, Bhattacharyya N. Contemporary assessment of medical morbidity and mortality in head and neck surgery[J]. Otolaryngol Head Neck Surg, 2012, 146(3): 385-389. DOI: 10.1177/0194599811428557. doi:10.1177/0194599811428557
[33]	Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review[J]. Radiother Oncol, 2003, 66(3): 253-262. DOI: 10.1016/s0167-8140(02)00404-8. doi:10.1016/s0167-8140(02)00404-8pmid:12742264
[34]	Vissink A, Mitchell JB, Baum BJ, et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers[J]. Int J Radiat Oncol Biol Phys, 2010, 78(4): 983-991. DOI: 10.1016/j.ijrobp.2010.06.052. doi:10.1016/j.ijrobp.2010.06.052
[35]	Sapir E, Tao Y, Feng F, et al. Predictors of dysgeusia in patients with oropharyngeal cancer treated with chemotherapy and intensity modulated radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2016, 96(2): 354-361. DOI: 10.1016/j.ijrobp.2016.05.011. doi:10.1016/j.ijrobp.2016.05.011
[36]	Siddiqui F, Movsas B. Management of radiation toxicity in head and neck cancers[J]. Semin Radiat Oncol, 2017, 27(4): 340-349. DOI: 10.1016/j.semradonc.2017.04.008. doi:S1053-4296(17)30039-5pmid:28865517
[37]	De Felice F, Musio D, Tombolini V. Osteoradionecrosis and intensity modulated radiation therapy: an overview[J]. Crit Rev Oncol Hematol, 2016, 107:39-43. DOI: 10.1016/j.critrevonc.2016.08.017. doi:10.1016/j.critrevonc.2016.08.017
[38]	Hermans R, Fossion E, Ioannides C, et al. CT findings in osteoradionecrosis of the mandible[J]. Skeletal Radiol, 1996, 25(1): 31-36. DOI: 10.1007/s002560050028. doi:10.1007/s002560050028pmid:8717116
[39]	Chen AM, Hall WH, Li BQ, et al. Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer[J]. Br J Radiol, 2011, 84(997): 58-63. DOI: 10.1259/bjr/62332495. doi:10.1259/bjr/62332495pmid:20858665
[40]	Chen AM, Hall WH, Li J, et al. Brachial plexus-associated neuro-pathy after high-dose radiation therapy for head-and-neck cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 84(1): 165-169. DOI: 10.1016/j.ijrobp.2011.11.019. doi:10.1016/j.ijrobp.2011.11.019
[41]	Chen J, Dassarath M, Yin Z, et al. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management[J]. Radiat Oncol, 2011, 6:128. DOI: 10.1186/1748-717X-6-128. doi:10.1186/1748-717X-6-128

中国头颈部肿瘤放射治疗指南(2021年版)

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表1

参考文献41

相关文章15

编辑推荐

Metrics

本文评价

[1]	陈琦, 徐晨阳, 王寅, 雷大鹏.高光谱成像在头颈部肿瘤诊疗中的应用现状[J]. 国际肿瘤学杂志, 2024, 51(5): 298-302.
[2]	中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会.中国食管癌放射治疗指南（2023年版）[J]. 国际肿瘤学杂志, 2024, 51(1): 1-20.
[3]	崔腾璐, 吕璐, 孙鹏飞.放疗联合免疫治疗在头颈部鳞状细胞癌治疗中的应用[J]. 国际肿瘤学杂志, 2023, 50(9): 548-552.
[4]	陈欣祎, 翁一鸣, 魏家燕, 王劲松, 彭敏.免疫检查点抑制剂在复发或转移性头颈部鳞状细胞癌治疗中的进展[J]. 国际肿瘤学杂志, 2023, 50(9): 553-557.
[5]	崔腾璐, 孙鹏飞.鼻咽低级别乳头状腺癌综合治疗1例并文献复习[J]. 国际肿瘤学杂志, 2023, 50(6): 382-384.
[6]	鞠逸凡, 徐晨阳, 雷大鹏.病理组学在头颈部肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(5): 294-298.
[7]	李进芝, 赵彪, 文晓博, 张明, 袁美芳, 孙梦真, 蒲琴, 杨毅.Monaco系统计算网格尺寸对T₄期鼻咽癌的剂量学影响[J]. 国际肿瘤学杂志, 2023, 50(11): 641-649.
[8]	许婷婷, 胡超苏, 李宝生.抗EGFR单抗治疗局部晚期头颈部鳞状细胞癌临床共识（2023年版）[J]. 国际肿瘤学杂志, 2023, 50(1): 1-11.
[9]	朱琪伟, 崔娟娟, 张紫寒, 杨燕光, 葛彬彬, 刘于, 储开岳.左侧乳腺癌术后内乳区域淋巴结照射的心脏剂量学分析和生命质量评估[J]. 国际肿瘤学杂志, 2023, 50(1): 17-21.
[10]	陈怡, 韩靓, 蔡雳.头颈部肿瘤患者化疗性口腔黏膜炎发生的多因素分析[J]. 国际肿瘤学杂志, 2022, 49(9): 521-525.
[11]	郭延勇, 刘森, 高远.SBRT联合mFOLFOXIRI和西妥昔单抗在结直肠癌术后肝转移瘤中的临床疗效和不良反应[J]. 国际肿瘤学杂志, 2022, 49(6): 340-344.
[12]	孙晓琳, 张展昱, 许林宗, 刘英超, 李晓梅.放疗联合免疫治疗在乳腺癌脑转移瘤中的潜在价值[J]. 国际肿瘤学杂志, 2022, 49(4): 243-246.
[13]	曾艳, 罗盼, 王子琪, 吴伟莉.药物在头颈部肿瘤治疗中引起铁死亡的作用机制[J]. 国际肿瘤学杂志, 2022, 49(3): 173-176.
[14]	纪环, 周菊英, 马辰莺, 徐晓婷, 秦颂兵.非小细胞肺癌脑转移的放疗进展[J]. 国际肿瘤学杂志, 2022, 49(3): 181-184.
[15]	李坪, 孙晓南.体部立体定向放射治疗联合免疫检查点抑制剂在非小细胞肺癌中的应用[J]. 国际肿瘤学杂志, 2022, 49(2): 116-120.